CADTH is committed to supporting Canada’s health care decision-makers through this challenging and uncertain time.
For evidence, tools, and resources related to COVID-19, visit our COVID-19 Evidence Portal.


Begin main content

News and Events

Latest News

Consultations Help Shape Updated Patient Input Guide

December 3, 2020
Feedback from more than 35 patient groups has helped CADTH update its Guidance for Providing Patient Input — a key resource for patient groups, patients, and caregivers who contribute to our reimbursement review process. The guide now addresses some of the key improvements suggested by patient groups, which include: expanding the definition ...

CADTH Recommends First Gene Therapy Treatment for Rare Form of Childhood Vision Loss

November 26, 2020
Voretigene neparvovec (Luxturna) is the first gene therapy evaluated through the CADTH reimbursement review process CADTH recommends reimbursement with conditions, including a price reduction, and offers advice on implementing the recommendation On November 16, CADTH recommended that Canada’s federal, provincial, and territorial drug pla...

2020 Virtual CADTH Symposium - New Content Available

November 25, 2020
Did you miss some of the great live sessions during the 2020 Virtual CADTH Symposium? Great news — our plenary and concurrent sessions are now available for on-demand viewing on the Symposium website. In more great news, we’ve added 30 new pre-recorded sessions that will bring you fresh insights on a range of topics, including: Artificial i...